Conmed Corp (FRA:EC8)
€ 64.5 0 (0%) Market Cap: 2.10 Bil Enterprise Value: 2.93 Bil PE Ratio: 17.58 PB Ratio: 2.45 GF Score: 70/100

Q3 2023 Conmed Corp Earnings Call Transcript

Oct 25, 2023 / 08:30PM GMT
Release Date Price: €89 (+1.14%)
Operator

Thank you for standing by, and welcome to CONMED's Q3 Fiscal Year 2023 Earnings Call. (Operator Instructions)

Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risks and uncertainties as those terms are defined under the Federal Securities laws. Investors are cautioned that any such forward-looking statements are not guarantees of future events, performance or results.

The company's actual results may differ materially from its current expectations. Please refer to the risks and other uncertainties disclosed under the forward-looking information in today's press release as well as the company's SEC filings for more details on the risks and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be disclosed during this call except as may be required by applicable law.

You will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot